Аннотация
Актуальность эндометриоза связана с широким распространением заболевания среди девочек-подростков и женщин репродуктивного возраста и вызванным им бесплодием, а также формированием стойкого болевого синдрома, негативно влияющим на качество жизни женщины. Проблема лечения пациенток с эндометриозом в современной гинекологии остается актуальной из-за высокой распространенности данной патологии, а также вследствие ее отрицательного влияния на репродуктивную систему и общее состояние здоровья женщины.
Литература
1. Клинические рекомендации. Эндометриоз. Минздрав РФ; 2016. с. 37.
2. Leyland N, Casper R, Laberge P, Singh SS, SOGC. Clinical practice guideline: diagnosis and managementof endometriosis. J Obstet Gynaecol Can. 2010; 32(7 Suppl 2): S1-32.
3. Wang WT, Sun YM, Huang W, He B, Zhao YN, Chen YQ. Genomewide Long Non-coding RNA Analysis Identified Circulating LncRNAs as Novel Non-invasive Diagnostic Biomarkers for Gynecological Disease. Sci Rep. 2016; 6: 233-243. doi: 10.1038/srep23343.
4. Dunselman GAJ, Vermeulen N, Becker C, Calhaz-Jorge C, D'Hooghe T, De Bie B et al. Management of women with endometriosis. Guideline of the European Society of Human Reproduction and Embryology (ESHRE) Hum Reproduct. 2014; 29(3): 400-412. doi: https://doi.org/10.1093/humrep/det457.
5. Grechukhina O, Petracco R, Popkhadze S, Massasa E, Paranjape T, Chan E et al. A polymorphism in a let-7 microRNA binding site of KRAS in women with endometriosis. EMBO Mol Med. 2012; 4: 206-17. doi: 10.1002/emmm.201100200.
6. Andres Mde P, Lopes LA, Baracat EC, Podgaec S. Dienogest in the treatment of endometriosis: systematic review. Arch Gynecol Obstet. 2015; 292(3): 523-529. doi: 10.1007/s00404-015-3681-6.
7. Wrona W, Stępniak А, Czuczwar Р. The role of levonorgestrel intrauterine systems in the treatment of symptomatic fibroids. Prz Menopauzalny. 2017; 16(4): 129–132. doi: 10.5114/pm.2017.72758.
8. Vercellini P, Viganò P, Somigliana E, Fedele L. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014; 10(5): 261-75. doi: 10.1038/nrendo.2013.255.
9. Endocrine disrupting chemicals and endometriosis / M. M. Smarr et al. Fert. Ster. 2016; 106: 959-966. doi: https://doi.org/10.1016/j.fertnstert.2016.06.034
10. ASRM. Revised American Society for Reproductive Medicine classification of endometriosis. Fertil Steril. 1997; 67: 817-821. doi: 10.1016/s0015-0282(97)81391-x.
11. Al-Inany HG, Youssef MA, Ayeleke R, Brown J, Lam W, Broekmans FJ. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane Database Syst Rev. 2016; 4: CD001750. doi: 10.1002/14651858.
12. Hickey M, Ballard K, Farquhar C. Endometriosis. BMJ. 2014; 348: 17-52. doi: 10.1136/bmj.g1752.
13. Brown J, Crawford TJ, Allen C, Hopewell S, Prentice A. Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis. Cochrane Database Syst Rev. 2017; 1: CD004753. doi: 10.1002/14651858.
14. Shah DK, Correia KF, Vitonis AF, Missmer SA. Body size and endometriosis: results from 20 years of follow-up within the Nurses’ Health Study II prospective cohort. Hum Reproduct. 2013; 28(7): 1783-1792. doi: 10.1093/humrep/det120.
15. Peterson C M, Johnstone E B, Hammoud A O, Stanford J B, Varner M W, Kennedy A et al. Risk factors associated with endometriosis: importance of study population for characterizing disease in the ENDO Study. Am J Obstet. Gynecol. 2013; 208: 451-463. doi: 10.1016/j.ajog.2013.02.040.
16. Farland L V, Tamimi R M, Eliassen A H, Spiegelman D, Hankinson S E, Chen W Y et al. Laparoscopically Confirmed Endometriosis and Breast Cancer in the Nurses' Health Study II. Obstet Gynecol. 2016; 128(5): 1025–1031. doi:10.1097/AOG.0000000000001684.
17. Vercellini P, Viganò P, Somigliana E, Fedele L. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2013; 7: 261-275. doi: 10.1038/nrendo.2013.
18. Mavrelos D, Saridogan E. Treatment of endometriosis in women desiring fertility. J Obstet Gynaecol India. 2015; 65(1): 11–16. doi:10.1007/s13224-014-0652-y.